{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "An institutional review board-approved, multicenter clinical trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients with a single focus of IDC 20 mm or smaller by pre-ablation MRI were treated with PLA."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients with a single focus of IDC 20 mm or smaller by pre-ablation MRI were treated with PLA."
      },
      "Objective": {
        "score": 1,
        "evidence": "to determine the efficacy and outcome of percutaneous laser ablation (PLA) in the treatment of invasive ductal breast carcinoma (IDC)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The patients underwent a 28-day post-ablation MRI, followed by surgical resection."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "In this study, 61 patients were reported as the intention-to-treat cohort"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Of these 61 patients, 51 (84%) had complete tumor ablation confirmed by pathology analysis."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The negative predictive value (NPV) of MRI for all the patients was 92.2% (95% confidence interval [CI], 71.9\u201391.9%)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 14,
    "max_score": 25
  },
  "model": "gpt-4o"
}